SOOD; Anil K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SOOD; Anil K..The latest application filed is for "nuclear-derived exosomes and methods of use thereof".

Company Profile

6.15.17

SOOD; Anil K. - Houston TX
SOOD; Anil K. - Pearland TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nuclear-derived Exosomes And Methods Of Use Thereof App 20220163532 - SOOD; Anil K. ; et al.	2022-05-26
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer Grant 11,090,266 - Vivas-Mejia , et al. August 17, 2	2021-08-17
Egfl6 Specific Monoclonal Antibodies And Methods Of Their Use App 20210130450 - ZHANG; Ningyan ; et al.	2021-05-06
EGFL6 specific monoclonal antibodies and methods of their use Grant 10,875,912 - Zhang , et al. December 29, 2	2020-12-29
Dual assembly nanoparticles Grant 10,874,622 - Aslan , et al. December 29, 2	2020-12-29
Nanoliposomal c-MYC-siRNA Inhibits In Vivo Tumor Growth of Cisplatin-Resistant Ovarian Cancer App 20200179284 - Vivas-Mejia; Pablo E. ; et al.	2020-06-11
Hybrid Exosomal-polymeric (hexpo) Nano-platform For Delivery Of Rnai Therapeutics App 20200069594 - SOOD; Anil K. ; et al.	2020-03-05
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer Grant 10,548,842 - Vivas-Mejia , et al. Fe	2020-02-04
Egfl6 Specific Monoclonal Antibodies And Methods Of Their Use App 20190031751 - ZHANG; Ningyan ; et al.	2019-01-31
Nanoliposomal c-MYC-siRNA Inhibits In Vivo Tumor Growth of Cisplatin-Resistant Ovarian Cancer App 20180185284 - Vivas-Mejia; Pablo E. ; et al.	2018-07-05
Dual Assembly Nanoparticles App 20180169029 - ASLAN; Burcu ; et al.	2018-06-21
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer Grant 9,895,312 - Vivas-Mejia , et al. February 20, 2	2018-02-20
Methods And Compositions Involving Chitosan Nanoparticles App 20160375050 - LOPEZ-BERESTEIN; Gabriel ; et al.	2016-12-29
Delivery of siRNA by neutral lipid compositions Grant 8,895,717 - Sood , et al. November 25, 2	2014-11-25
HDL particles for delivery of nucleic acids Grant 8,734,853 - Sood , et al. May 27, 2	2014-05-27
Detection of Cancer by Volatile Organic Compounds From Breath App 20140127326 - Sood; Anil K. ; et al.	2014-05-08
Methods and compositions related to wrapping of dehydrons Grant 8,466,154 - Fernandez , et al. June 18, 2	2013-06-18
Methods And Compositions Related To Wrapping Of Dehydrons App 20130131076 - Fernandez; Ariel ; et al.	2013-05-23
Methods And Compositions Related To Prefoldin And Its Regulation App 20120070486 - Sood; Anil K. ; et al.	2012-03-22
HDL Particles for Delivery of Nucleic Acids App 20110312899 - Sood; Anil K. ; et al.	2011-12-22
Therapeutic targeting of interleukins using siRNA in neutral liposomes Grant 8,067,390 - Merritt , et al. November 29, 2	2011-11-29
Therapeutic Targeting Of Interleukins Using Sirna In Neutral Liposomes App 20100172962 - Merritt; William M. ; et al.	2010-07-08
Delivery of Sirna by Neutral Lipid Compositions App 20090012021 - Sood; Anil K. ; et al.	2009-01-08

Company Registrations

NCAGE Code	3SFE6	SOOD, ANIL K
CAGE Code	3SFE6	SOOD, ANIL K
S.A.M. Registration	3SFE6 [144519241]	SOOD, ANIL K
DUNS	144519241	SOOD, ANIL K

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.